Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports

INTRODUCTION: In late 2019, a new coronavirus—severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)—was discovered in Wuhan, China, and the World Health Organization later declared coronavirus disease 2019 (COVID-19) a pandemic. Numerous drugs have been repurposed and investigated for therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Zekarias, Alem, Watson, Sarah, Vidlin, Sara Hedfors, Grundmark, Birgitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518652/
https://www.ncbi.nlm.nih.gov/pubmed/32978702
http://dx.doi.org/10.1007/s40264-020-01000-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518652/
https://www.ncbi.nlm.nih.gov/pubmed/32978702
http://dx.doi.org/10.1007/s40264-020-01000-8

Ejemplares similares